Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.64 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.64 |
| ▸ | TSHR | P16473 | 1/20 | 0.64 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.64 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.64 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.60 |
| ▸ | SOAT1 | P35610 | 3/20 | 0.53 |
| ▸ | SOAT2 | O75908 | 2/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.53 |
| ▸ | LMNA | P02545 | 4/20 | 0.53 |
| ▸ | MEN1 | O00255 | 4/20 | 0.52 |
| ▸ | DRD3 | P35462 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 2/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.48 |
| ▸ | MC4R | P32245 | 1/20 | 0.48 |
| ▸ | SCN4A | P35499 | 1/20 | 0.48 |
| ▸ | MC3R | P41968 | 1/20 | 0.48 |
| ▸ | HTR3A | P46098 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Disofenin SCHEMBL29687882 | 0.98 | TDP1 (0.62) | TDP1ALOX15TSHRCYP2C19HIF1A | |
| SCHEMBL9679857 | 0.90 | SOAT2 (0.57) | TDP1ALOX15TSHRCYP2C19HIF1A | |
| SCHEMBL9491944 | 0.86 | LMNA (0.65) | TDP1ALOX15TSHRCYP2C19HIF1A | |
| SCHEMBL9679656 | 0.84 | SOAT2 (0.60) | TDP1SMN1; SMN2SOAT1SOAT2KMT2A | |
| SCHEMBL20763994 | 0.83 | SMN1; SMN2 (0.66) | TDP1SMN1; SMN2SOAT1SOAT2KMT2A | |
| SCHEMBL2148218 | 0.82 | SMN1; SMN2 (0.70) | TDP1SMN1; SMN2SOAT1SOAT2KMT2A | |
| Disofenin SCHEMBL7825569 | 0.81 | ALOX15 (0.45) | TDP1ALOX15TSHRCYP2C19HIF1A | |
| Benzene SCHEMBL9851028 | 0.81 | SMN1; SMN2 (0.68) | TDP1SMN1; SMN2SOAT1SOAT2KMT2A | |
| SCHEMBL9843936 | 0.80 | SMN1; SMN2 (0.77) | TDP1SMN1; SMN2SOAT1SOAT2KMT2A | |
| Lidofenin SCHEMBL214472 | 0.80 | MAPT (0.73) | TDP1ALOX15TSHRCYP2C19HIF1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1137 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260137621-A1 | ORALLY BIOAVAILABLE LIPID-BASED CONSTRUCTS | DIASOME PHARMACEUTICALS INC (US) | 2026-05-21 | — | — | US | claimed |
| US-20250288521-A1 | ORALLY BIOAVAILABLE LIPID-BASED CONSTRUCTS | DIASOME PHARMACEUTICALS INC (US) | 2025-09-18 | — | — | US | claimed |
| US-20250121100-A1 | COMPOSITION AND METHOD FOR DIAGNOSTIC IMAGING | SUNTEC MEDICAL INC (US) | 2025-04-17 | — | — | US | claimed |
| CN-119698306-A | Compositions and methods for diagnostic imaging | 欣扬生医股份有限公司 | 2025-03-25 | — | — | CN | claimed |
| US-20250091013-A1 | Three-Compartment Bipolar Membrane Electrodialysis Of Salts Of Amino Acids | MONSANTO TECHNOLOGY LLC | 2025-03-20 | — | — | US | claimed |
| US-20240158423-A1 | TWO-COMPARTMENT BIPOLAR MEMBRANE ELECTRODIALYSIS OF SALTS OF AMINO ACIDS | MONSANTO TECHNOLOGY LLC | 2024-05-16 | — | — | US | claimed |
| EP-4301763-A1 | TWO-COMPARTMENT BIPOLAR MEMBRANE ELECTRODIALYSIS OF SALTS OF AMINO ACIDS | Monsanto Technology LLC (US) | 2024-01-10 | — | — | EP | claimed |
| US-20230201386-A1 | PRODUCING RADIOPHARMACEUTICAL COLD KITS WITHOUT LYOPHILIZATION | THE BOARD OF REGENTS OF THE UNIVERSITY OF OKLAHOMA | 2023-06-29 | — | — | US | claimed |
| WO-2022187407-A1 | TWO-COMPARTMENT BIPOLAR MEMBRANE ELECTRODIALYSIS OF SALTS OF AMINO ACIDS | MONSANTO TECHNOLOGY LLC (US) | 2022-09-09 | — | — | WO | claimed |
| CN-114366825-A | Response type isotope targeting drug and preparation method and application thereof | 中国科学院宁波材料技术与工程研究所慈溪生物医学工程研究所 | 2022-04-19 | — | — | CN | claimed |
| EP-1087753-A1 | TARGETED LIPOSOMAL DRUG DELIVERY SYSTEM | SDG, Inc. (US) | 2001-04-04 | — | — | EP | claimed |
| CN-1264310-A | Polymer based pharmaceutical compositions for targeted delivery of biologically active agents | SDG INC (US) | 2000-08-23 | — | — | CN | claimed |
| EP-1005327-A1 | TARGETED LIPOSOMAL CONSTRUCTS FOR DIAGNOSTIC AND THERAPEUTIC USES | SDG, INC. (US) | 2000-06-07 | — | — | EP | claimed |
| US-6063400-A | CARRIER; DIAGNOSTIC OR THERAPEUTIC AGENT AND SEQUESTERING AGENT | SDG, INC. (US) | 2000-05-16 | — | — | US | claimed |
| WO-1999059545-A9 | TARGETED LIPOSOMAL DRUG DELIVERY SYSTEM | SDG INC (US) | 2000-04-27 | — | — | WO | claimed |
| WO-1999059545-A1 | TARGETED LIPOSOMAL DRUG DELIVERY SYSTEM | SDG, INC. (US) | 1999-11-25 | — | — | WO | claimed |
| WO-1999001110-A1 | TARGETED LIPOSOMAL CONSTRUCTS FOR DIAGNOSTIC AND THERAPEUTIC USES | SDG, INC. (US) | 1999-01-14 | — | — | WO | claimed |
| US-5225182-A | For specific organ delivery | SHARMA YASH P (US) | 1993-07-06 | — | — | US | claimed |
| EP-0166746-B1 | PREPARATION OF ?99M TC RADIOPHARMACEUTICALS | THE COMMONWEALTH OF AUSTRALIA (AU) | 1991-04-24 | — | — | EP | claimed |
| WO-1985003063-A1 | PREPARATION OF 99mTC RADIOPHARMACEUTICALS | THE COMMONWEALTH OF AUSTRALIA (AU) | 1985-07-18 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250288521-A1 | ORALLY BIOAVAILABLE LIPID-BASED CONSTRUCTS | FABP2, FABP1, FABP6 | TDP1 4819/4885ALOX15 414/4885TSHR 161/4885 |
| US-20250091013-A1 | Three-Compartment Bipolar Membrane Electrodialysis Of Salts Of Amino Acids | SLC1A3, SLC1A2, SLC1A1 | TDP1 3832/4885ALOX15 4491/4885TSHR 1514/4885 |
| US-20260137621-A1 | ORALLY BIOAVAILABLE LIPID-BASED CONSTRUCTS | FABP2, FABP1, SGMS2 | TDP1 4755/4885ALOX15 3077/4885TSHR 367/4885 |
| US-20250121100-A1 | COMPOSITION AND METHOD FOR DIAGNOSTIC IMAGING | ABCB4, C5, APOB | TDP1 3106/4885ALOX15 2592/4885TSHR 4788/4885 |
| US-20240158423-A1 | TWO-COMPARTMENT BIPOLAR MEMBRANE ELECTRODIALYSIS OF SALTS OF AMINO ACIDS | SLC1A2, SLC5A11, SLC3A2 | TDP1 2236/4885ALOX15 4660/4885TSHR 2427/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.